- ICH GCP
- Registro degli studi clinici negli Stati Uniti
- Sperimentazione clinica NCT07614386
Radial Access Data in Vascular Interventions Registry (RADIUS)
Radial Access Data in Vascular Interventions: A Prospective Observational Registry Study
The RADIUS study is a prospective observational registry designed to collect real-world data regarding radial and ulnar artery access in percutaneous vascular interventions. The study aims to evaluate procedural characteristics, access-site complications, procedural success, and short-term clinical outcomes associated with transradial and transulnar vascular access.
Patients undergoing routine percutaneous vascular interventions via radial or ulnar artery access at Mersin Medical Park Hospital will be consecutively enrolled. Demographic, clinical, angiographic, procedural, and post-procedural data will be prospectively collected and analyzed.
The study was initially designed as a single-center registry; however, following Institutional Review Board (IRB) approval, expansion into a multicenter registry with participating centers is planned.
This study is observational in nature and does not involve any experimental treatment, device, or intervention beyond standard clinical care.
Panoramica dello studio
Stato
Condizioni
Intervento / Trattamento
Descrizione dettagliata
The RADIUS (Radial Access Data in Vascular Interventions) study is a prospective observational registry designed to systematically collect real-world data regarding radial and ulnar artery access in percutaneous vascular interventions.
Transradial access has become increasingly preferred in contemporary interventional practice because of lower bleeding risk, improved patient comfort, earlier mobilization, and reduced vascular complications compared with traditional femoral access. In addition, transulnar access has emerged as an alternative vascular access strategy in selected patients. Despite the increasing adoption of radial and ulnar access techniques, comprehensive real-world registry data evaluating procedural characteristics, vascular complications, procedural success, and clinical outcomes remain limited.
The RADIUS registry aims to evaluate demographic, clinical, angiographic, procedural, and post-procedural characteristics of patients undergoing percutaneous vascular interventions through radial or ulnar artery access. Particular focus will be placed on access-site complications, including radial artery spasm, radial artery occlusion, bleeding complications, crossover to alternative access sites, vascular injury, and short-term clinical outcomes.
The study will enroll consecutive adult patients undergoing routine percutaneous vascular interventions via radial or ulnar artery access at Mersin Medical Park Hospital between May 2026 and May 2031. Data will be prospectively collected from procedural reports, hospital electronic medical records, and routine clinical evaluations.
Collected variables will include demographic characteristics, cardiovascular risk factors, comorbidities, laboratory findings, angiographic and procedural details, vascular access characteristics, procedural duration, fluoroscopy time, contrast volume, devices and techniques used during procedures, procedural success rates, and in-hospital and short-term complications.
The study was initially designed as a single-center registry; however, expansion into a multicenter registry involving additional participating centers is planned following Institutional Review Board (IRB) approval and local regulatory processes.
This registry is purely observational in nature and does not involve any experimental drug, device, or intervention beyond standard clinical care. All procedures and treatment strategies will be performed according to current routine clinical practice and operator discretion.
Data obtained from the registry will be analyzed using appropriate statistical methods, and the results are expected to contribute to the understanding and optimization of radial and ulnar access strategies in vascular interventions and support future scientific publications.
Tipo di studio
Iscrizione (Stimato)
Contatti e Sedi
Contatto studio
- Nome: Sefa SURAL, MD
- Numero di telefono: +90 532 565 01 60
- Email: sesural@hotmail.com
Backup dei contatti dello studio
- Nome: Gökhan AVCI, MD
- Numero di telefono: +90 506 228 57 09
- Email: drgavci@hotmail.com
Luoghi di studio
-
-
Mezitli
-
Mersin, Mezitli, Turchia (Türkiye), 33010
- Reclutamento
- Mersin Medicalpark hospital
-
Contatto:
- Sefa Sural, MD
- Numero di telefono: +905325650160
- Email: sesural@hotmail.com
-
Contatto:
- Gökhan AVCI, MD
- Email: drgavci@gmail.com
-
Sub-investigatore:
- Vedat ASLAN, MD
-
-
Criteri di partecipazione
Criteri di ammissibilità
Età idonea allo studio
- Adulto
- Adulto più anziano
Accetta volontari sani
Metodo di campionamento
Popolazione di studio
Descrizione
Inclusion Criteria:
- Age ≥18 years
- Patients undergoing routine percutaneous vascular interventions via radial or ulnar artery access
- Ability to provide informed consent
Exclusion Criteria:
- Age <18 years
- Procedures performed without radial or ulnar artery access
- Incomplete procedural or clinical data
- Refusal to participate in the registry
Piano di studio
Come è strutturato lo studio?
Dettagli di progettazione
Coorti e interventi
Gruppo / Coorte |
Intervento / Trattamento |
|---|---|
|
Radial and Ulnar Access Registry Cohort
Patients undergoing routine percutaneous vascular interventions via radial or ulnar artery access.
|
Routine percutaneous vascular interventions performed via radial or ulnar artery access according to standard clinical practice.
|
Cosa sta misurando lo studio?
Misure di risultato primarie
Misura del risultato |
Misura Descrizione |
Lasso di tempo |
|---|---|---|
|
Radial Artery Occlusion Rate
Lasso di tempo: Within 1 year after procedure
|
Incidence of radial artery occlusion following percutaneous vascular interventions performed via radial artery access.
|
Within 1 year after procedure
|
|
Access-Site Vascular Complication Rate
Lasso di tempo: through study completion, an average of 1 year
|
Incidence of vascular access-site complications including bleeding, hematoma, pseudoaneurysm, arterial dissection, and vascular injury.
|
through study completion, an average of 1 year
|
|
Radial Artery Spasm Rate
Lasso di tempo: During Procedure
|
Incidence of clinically significant radial artery spasm during or immediately after the procedure.
|
During Procedure
|
Misure di risultato secondarie
Misura del risultato |
Misura Descrizione |
Lasso di tempo |
|---|---|---|
|
Procedural Success Rate
Lasso di tempo: During procedure
|
Successful completion of the planned vascular intervention using radial or ulnar artery access without crossover to alternative access.
|
During procedure
|
|
Crossover Rate
Lasso di tempo: During Procedure
|
Need for conversion from radial or ulnar access to another vascular access site during the procedure.
|
During Procedure
|
|
Bleeding Complications
Lasso di tempo: During Procedure
|
Incidence of access-site or non-access-site bleeding complications following the procedure.
|
During Procedure
|
|
Fluoroscopy Time
Lasso di tempo: During Procedure
|
Total fluoroscopy time during the procedure, measured in minutes.
|
During Procedure
|
|
Length of Hospital Stay
Lasso di tempo: From the date of vascular intervention until hospital discharge, assessed up to 30 days
|
Duration of hospitalization following vascular intervention, measured in days from the date of the procedure until hospital discharge.
|
From the date of vascular intervention until hospital discharge, assessed up to 30 days
|
|
Contrast Volume
Lasso di tempo: During Procedure
|
Total volume of contrast agent administered during the procedure, measured in milliliters (mL).
|
During Procedure
|
Collaboratori e investigatori
Sponsor
Investigatori
- Direttore dello studio: Sefa SURAL, MD, Toros University
Studiare le date dei record
Studia le date principali
Inizio studio (Effettivo)
Completamento primario (Stimato)
Completamento dello studio (Stimato)
Date di iscrizione allo studio
Primo inviato
Primo inviato che soddisfa i criteri di controllo qualità
Primo Inserito (Effettivo)
Aggiornamenti dei record di studio
Ultimo aggiornamento pubblicato (Effettivo)
Ultimo aggiornamento inviato che soddisfa i criteri QC
Ultimo verificato
Maggiori informazioni
Termini relativi a questo studio
Parole chiave
Termini MeSH pertinenti aggiuntivi
Altri numeri di identificazione dello studio
- SRL-RADIUS-001
Piano per i dati dei singoli partecipanti (IPD)
Hai intenzione di condividere i dati dei singoli partecipanti (IPD)?
Descrizione del piano IPD
Informazioni su farmaci e dispositivi, documenti di studio
Studia un prodotto farmaceutico regolamentato dalla FDA degli Stati Uniti
Studia un dispositivo regolamentato dalla FDA degli Stati Uniti
Queste informazioni sono state recuperate direttamente dal sito web clinicaltrials.gov senza alcuna modifica. In caso di richieste di modifica, rimozione o aggiornamento dei dettagli dello studio, contattare register@clinicaltrials.gov. Non appena verrà implementata una modifica su clinicaltrials.gov, questa verrà aggiornata automaticamente anche sul nostro sito web .
Prove cliniche su Disfunsione dell'arteria coronaria
-
I.R.C.C.S Ospedale Galeazzi-Sant'AmbrogioReclutamentoCoronary Artery DiseaseItalia
-
Tel-Aviv Sourasky Medical CenterCompletatoSoggetti consecutivi che sono idonei per una coronaria | Angioplastica di de Novo Lesion(s) in Native Coronary | Le arterie dovrebbero essere sottoposte a screening per l'idoneità. | Un numero totale di 200 pazienti che soddisfano la selezione | Criteri e disponibilità a firmare il consenso... e altre condizioniIsraele
Prove cliniche su Radial and Ulnar Artery Access
-
University of Alabama at BirminghamJohns Hopkins University; Birmingham AIDS Outreach; AIDS UnitedCompletatoInfezione da HIV | Perdita di cure per l'HIV al follow-up